ReviewWorld journal of urology2025
Cross-talk between Pseudomonas aeruginosa and urinary tract infections.
Review in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Ultrasensitive Label-Free Electrochemical Detection ofPolymers · 2026Article
- Genetic Analysis of Virulence and β-Lactamase Determinants Related to β-Lactamase Inhibitors inAntibiotics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Pseudomonas aeruginosa, a key member of the ESKAPE pathogen group, is a common cause of urinary tract infections (UTIs), particularly in patients with indwelling urinary catheters. Due to its large genome, P. aeruginosa has a high potential for genetic mutations, enabling the development of multidrug resistance. Additionally, it produces a variety of virulence factors, which contribute to persistent and often refractory infections. While UTIs caused by Escherichia coli have been extensively studied, those caused by P. aeruginosa remain less well understood. Understanding the mechanisms underlying the occurrence and progression of P. aeruginosa-associated UTIs, as well as the evolution of its antimicrobial resistance, is crucial for developing more effective treatment strategies. This paper provides an overview of the interaction between P. aeruginosa and UTIs, offering insights that could aid in more effective management and eradication of P. aeruginosa in the urinary tract.
Indexed as
Identifiers
40540108What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.